#AstraZeneca — FinScans

News 📈 Stocks

AstraZeneca Camizestrant Approval Poised to Drive SERD Market Growth

October 5, 2026 (12 days ago)

AstraZeneca's camizestrant approval acts as a catalyst for the expanding SERD market, with growth driven by demographic shifts and advancements in breast…

AZN

🌍 GLOBAL Read More →

News 📈 Stocks

AstraZeneca Shares Drop on Report of Mega-Merger Talks With Bristol Myers

August 3, 2026 (76 days ago)

AstraZeneca shares fell on news of preliminary merger talks with Bristol Myers, sparking investor concerns over deal execution and antitrust risks.

AZN BMY

🌍 GB Read More →

News 📈 Stocks

AstraZeneca Stock Tumbles as Heart Drug Trial Fails

July 9, 2026 (101 days ago)

AstraZeneca stock drops following unexpected failure of a heart disease drug trial.

AZN

🌍 UK Read More →